Interleukin-7 levels in synovial fluid increase with age and MMP-1 levels decrease with progression of osteoarthritis

Acta Orthopaedica

Volumn 83, Issue 1, 2012, Pages 59-64

  Rbenhagen, René ^a   Schttrumpf, Jan Philipp ^a   Strmer, Klaus Michael ^a   Frosch, Karl Heinz ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Asklepios Clinic   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 18; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN;

ADOLESCENT; ADULT; AGE; ARTICLE; BIOCHEMISTRY; BODY MASS; CARTILAGE; CARTILAGE CELL; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KNEE ARTHROPLASTY; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; PROTEIN FUNCTION; SYNOVIAL FLUID; SYNOVIAL FLUID LEVEL;

ADULT; AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; CELL AGING; CHEMOKINE CCL2; CHONDROCYTES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOASSAY; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-18; INTERLEUKIN-6; INTERLEUKIN-7; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASES; MIDDLE AGED; OSTEOARTHRITIS; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84856860489     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.3109/17453674.2011.645195     Document Type: Article

References (31)

1. Anitua E, Sánchez M, de la Fuente M, Azofra J, Zalduendo M, Aguirre J J, Andía I. Relationship between investigative biomarkers and radiographic grading in patients with knee osteoarthritis. Int J Rheumatol 2009; 2009: 747432.
2. Ashraf S, Walsh D A. Angiogenesis in osteoarthritis. Curr Opin Rheumatol 2008; 20 (5): 573-80.
3. Belo J N, Berger M Y, Reijman M, Koes B W, Bierma-Zeinstra S M. Prognostic factors of progression of osteoarthritis of the knee: a systematic review of observational studies. Arthritis Rheum 2007; 57 (1): 13-26.
4. Borzì R M, Mazzetti I, Marcu K B, Facchini A. Chemokines in cartilage degradation. Clin Orthop (Suppl) 2004; (427): 53-61.
5. Calich A L, Domiciano D S, Fuller R. Osteoarthritis: can anti-cytokine therapy play a role in treatment? Clin Rheumatol 2010; 29 (5): 451-5.
6. Englund M. The role of biomechanics in the initiation and progression of OA of the knee. Best Pract Res Clin Rheumatol 2010; 24 (1): 39-46.
7. Fernandes J C, Martel-Pelletier J, Pelletier J P. The role of cytokines in osteoarthritis pathophysiology. Biorheology 2002; 39 (1-2): 237-46. (Pubitemid 34626067)
8. Freemont A J, Hampson V, Tilman R, Goupille P, Taiwo Y, Hoyland J A. Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specifc. Ann Rheum Dis 1997; 56 (9): 542-9. (Pubitemid 27428477)
9. Gardner E M, Murasko D M. Age-related changes in Type 1 and Type 2 cyto-kine production in humans. Biogerontology 2002; 3: 271-89. (Pubitemid 35174240)
10. Goldring M B, Goldring S R. Osteoarthritis. J Cell Physiol 2007; 213 (3): 626-34. (Pubitemid 350058254)
11. Irie K, Uchiyama E, Iwaso H. Intraarticular infammatory cytokines in acute anterior cruciate ligament injured knee. Knee 2003; 10 (1): 93-6. (Pubitemid 36324521)
12. Jouglin M, Robert C, Valette J P, Gavard F, Quintin-Colonna F, Denoix J M. Metalloproteinases and tumor necrosis factor-alpha activities in synovial fuids of horses: correlation with articular cartilage alterations. Ve t Res 2000; 31: 507.
13. Kellgren J H, Lawrence J S. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957; 16 (4): 494-502.
14. Kittipatarin C, Khaled A R. Interlinking interleukin-7. Cytokine 2007; 39 (1): 75-83. (Pubitemid 47446258)
15. Klatt A R, Paul-Klausch B, Klinger G, Kühn G, Renno J H, Banerjee M, Malchau G, Wielckens K. A critical role for collagen II in cartilage matrix degradation: collagen II induces pro-infammatory cytokines and MMPs in primary human chondrocytes. J Orthop Res 2009; 27 (1): 65-70.
16. Koch A E, Halloran M M, Hosaka S, Shah M R, Haskell C J, Baker SK, Panos R J, Haines G K, Bennett G L, Pope R M, Ferrara N. Hepatocyte growth factor. A cytokine mediating endothelial migration in infammatory arthritis. Arthritis Rheum 1996; 39 (9): 1566-75. (Pubitemid 26314991)
17. Little C B, Barai A, Burkhardt D, Smith S M, Fosang A J, Werb Z, Shah M, Thompson E W. Matrix metalloproteinase 13-defcient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteo-phyte development. Arthritis Rheum 2009; 60 (12): 3723-33.
18. Long D, Blake S, Song X Y, Lark M, Loeser R F. Human articular chondro-cytes produce IL-7 and respond to IL-7 with increased production of matrix metalloproteinase-13. Arthritis Res Ther 2008; 10: R23.
19. Martin J A, Buckwalter J A. Aging, articular cartilage chondrocyte senescence and osteoarthritis. Biogerontology 2002; 3: 257-64. (Pubitemid 35174238)
20. Monfort J, Garcia-Giralt N, López-Armada M J, Monllau J C, Bonilla A, Benito P, Blanco F J. Decreased metalloproteinase production as a response to mechanical pressure in human cartilage: a mechanism for homeostatic regulation. Arthritis Res Ther 2006; 8 (5): R149.
21. Murata M, Yudoh K, Masuko K. The potential role of vascular endothelial growth factor (VEGF) in cartilage: how the angiogenic factor could be involved in the pathogenesis of osteoarthritis? Osteoarthritis Cartilage 2008; 16 (3): 279-86. (Pubitemid 351309189)
22. Nguyen Q, Mort J S, Roughley P J. Preferential mRNA expression of pros-tromelysin relative to procollagenase and in situ localization in human articular cartilage. J Clin Invest 1992; 89 (4): 1189-97.
23. Pardo A, Selman M. MMP-1: the elder of the family. Int J Biochem Cell Biol 2005; 37 (2): 283-8. (Pubitemid 39330190)
24. Pfander D, Körtje D, Zimmermann R, Weseloh G, Kirsch T, Gesslein M, Cramer T, Swoboda B. Vascular endothelial growth factor in articular cartilage of healthy and osteoarthritic human knee joints. Ann Rheum Dis 2001; 60: 1070-3. (Pubitemid 32989184)
25. Shane Anderson A, Loeser R F. Why is osteoarthritis an age-related disease? Best Pract Res Clin Rheumatol 2010; 24 (1): 15-26.
26. Sun H B, Nalim R, Yokota H. Expression and activities of matrix metallopro-teinases under oscillatory shear in IL-1-stimulated synovial cells. Connect Tissue Res 2003; 44 (1): 42-9. (Pubitemid 36395470)
27. Takaishi H, Kimura T, Dalal S, Okada Y, D'Armiento J. Joint diseases and matrix metalloproteinases: a role for MMP-13. Curr Pharm Biotechnol 2008; 9 (1): 47-54. (Pubitemid 351266969)
28. van Roon J A, Lafeber F P. Role of interleukin-7 in degenerative and infam-matory joint diseases. Arthritis Res Ther 2008; 10 (2): 107.
29. Watanabe T, Kukita T, Kukita A, Wada N, Toh K, Nagata K, Nomiyama H, Iijima T. Direct stimulation of osteoclastogenesis by MIP-1alpha: evidence obtained from studies using RAW264 cell clone highly responsive to RANKL. J Endocrinol 2004; 180: 193-201. (Pubitemid 38180771)
30. Yuan G H, Masuko-Hongo K, Sakata M, Tsuruha J, Onuma H, Nakamura H, Aoki H, Kato T, Nishioka K. The role of C-C chemokines and their receptors in osteoarthritis. Arthritis Rheum 2001; 44 (5): 1056-70. (Pubitemid 32433611)
31. Yudoh K, Nguyen T, Nakamura H, Hongo-Masuko K, Kato T, Nishioka K. Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function. Arthritis Res Ther 2005; 7 (2): R380-91.